• Guidance for market authorization requirements for COVID-19 drugs: Overview
• Guidance for market authorization requirements for COVID-19 drugs: Labelling and post-market requirements
• Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements
• Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and …
• Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and …